
Please try another search
Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. In addition, it develops in vivo CAR-M cell therapy to treat solid tumors, including hepatocellular carcinoma. Carisma Therapeutics, Inc. has collaboration and license agreement with ModernaTX, Inc. to address oncology gene therapies. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. Carisma Therapeutics, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
Name | Age | Since | Title |
---|---|---|---|
Steven Kelly | 60 | 2023 | President, CEO & Director |
Briggs Duncan W. Morrison | 65 | 2023 | Independent Director |
Saar Gill | - | - | Co-Founder & Chairman of Scientific Advisory Board |
Prasad S. Adusumilli | - | 2020 | Member of Scientific Advisory Board |
Nina Bhardwaj | - | 2020 | Member of Scientific Advisory Board |
Marella Thorell | 58 | 2024 | Independent Director |
Lisa M. Coussens | - | - | Member of Scientific Advisory Board |
Carl H. June | 71 | - | Member of Scientific Advisory Board |
Scott L. Friedman | - | 2024 | Member of Scientific Advisory Board |
Lin Guey | - | 2023 | Member of Scientific Advisory Board |
Sanford S. Zweifach | 69 | 2023 | Independent Chairman of the Board |
Hyam I. Levitsky | 67 | - | Member of Scientific Advisory Board |
Ira Tabas | - | 2024 | Member of Scientific Advisory Board |
John A. Hohneker | 65 | 2024 | Independent Director |
Sohanya Cheng | 42 | 2024 | Independent Director |
David T. Scadden | 72 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review